InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Huang Jane, Chief Medical Officer, Hematology. Director active across 2 companies, notably BeiGene, Ltd.. In total, 24 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €1.6m. History available since 29 April 2021. The latest transaction was disclosed on 14 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Huang Jane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
9,375 sharesCommon StockSEC:0001683913-25-000004:0
9,375 sharesCommon StockSEC:0001562180-25-005346:0
9,375 sharesCommon StockSEC:0001562180-25-003036:0
9,375 sharesCommon StockSEC:0001562180-25-000237:0
9,375 sharesCommon StockSEC:0001562180-24-007253:0
9,375 sharesCommon StockSEC:0001562180-24-005641:0
9,375 sharesCommon StockSEC:0001562180-24-003347:0
9,375 sharesCommon StockSEC:0001562180-24-000338:0
9,375 sharesCommon StockSEC:0001562180-23-007230:0
9,375 sharesCommon StockSEC:0001209191-23-041553:0
37,500 sharesCommon StockSEC:0001562180-23-003481:0
1,500 shares@ US$119.960.0005% mcap2.2% of flowAmerican Depositary SharesSEC:0001651308-21-000255:0
14,820 shares0Ordinary SharesSEC:0001651308-21-000237:0
1,500 shares@ US$119.964.4% of flowAmerican Depositary SharesSEC:0001651308-21-000230:0
1,500 shares@ US$119.964.3% of flowAmerican Depositary SharesSEC:0001651308-21-000209:0
6,000 shares@ US$119.9616.9% of flowAmerican Depositary SharesSEC:0001651308-21-000196:0
4,219 shares@ US$355.370634.9% of flowAmerican Depositary SharesSEC:0001651308-21-000192:0
7,163 shares0Ordinary SharesSEC:0001651308-21-000188:0
6,914 shares@ US$160.4025.8% of flowAmerican Depositary SharesSEC:0001651308-21-000154:0
425 shares@ US$365.003.6% of flowAmerican Depositary SharesSEC:0001651308-21-000140:0
25,350 shares0Ordinary SharesSEC:0001651308-21-000126:0
603 shares@ US$351.55154.8% of flowAmerican Depositary SharesSEC:0001651308-21-000107:0
7,189 shares0Ordinary SharesSEC:0001651308-21-000099:0
1,500 shares@ US$29.491.0% of flowAmerican Depositary SharesSEC:0001651308-21-000078:0
24 of 24 declarations
About Huang Jane
Huang Jane is Chief Medical Officer, Hematology. She has filed 24 filings in total, and the sampled recent filings cover the period from 2021-05-03 to 2025-10-07, with sell transactions totaling EUR 1573205 and no buys, mainly related to BeiGene, Ltd. and Prelude Therapeutics Inc.
